Cargando…
P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431082/ http://dx.doi.org/10.1097/01.HS9.0000971356.50570.ac |
| _version_ | 1785091115323490304 |
|---|---|
| author | Walewski, Jan Min Kim, Tae Cho, Seok-Goo Jarque, Isidro Iskierka-Jażdżewska, Elżbieta Poon, Michelle Miles Prince, H. Yong Oh, Sung Lim, Francesca Segura, Cecilia Carmen Carpio Tan, Tran-Der Ayyappan, Sabarish Gutiérrez, Antonio LI, Jingjin Ufkin, Melanie Zhu, Min Chaudhry, Aafia Mohamed, Hesham Ambati, Srikanth Kim, Won-Seog |
| author_facet | Walewski, Jan Min Kim, Tae Cho, Seok-Goo Jarque, Isidro Iskierka-Jażdżewska, Elżbieta Poon, Michelle Miles Prince, H. Yong Oh, Sung Lim, Francesca Segura, Cecilia Carmen Carpio Tan, Tran-Der Ayyappan, Sabarish Gutiérrez, Antonio LI, Jingjin Ufkin, Melanie Zhu, Min Chaudhry, Aafia Mohamed, Hesham Ambati, Srikanth Kim, Won-Seog |
| author_sort | Walewski, Jan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431082 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104310822023-08-17 P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 Walewski, Jan Min Kim, Tae Cho, Seok-Goo Jarque, Isidro Iskierka-Jażdżewska, Elżbieta Poon, Michelle Miles Prince, H. Yong Oh, Sung Lim, Francesca Segura, Cecilia Carmen Carpio Tan, Tran-Der Ayyappan, Sabarish Gutiérrez, Antonio LI, Jingjin Ufkin, Melanie Zhu, Min Chaudhry, Aafia Mohamed, Hesham Ambati, Srikanth Kim, Won-Seog Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431082/ http://dx.doi.org/10.1097/01.HS9.0000971356.50570.ac Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Walewski, Jan Min Kim, Tae Cho, Seok-Goo Jarque, Isidro Iskierka-Jażdżewska, Elżbieta Poon, Michelle Miles Prince, H. Yong Oh, Sung Lim, Francesca Segura, Cecilia Carmen Carpio Tan, Tran-Der Ayyappan, Sabarish Gutiérrez, Antonio LI, Jingjin Ufkin, Melanie Zhu, Min Chaudhry, Aafia Mohamed, Hesham Ambati, Srikanth Kim, Won-Seog P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 |
| title | P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 |
| title_full | P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 |
| title_fullStr | P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 |
| title_full_unstemmed | P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 |
| title_short | P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 |
| title_sort | p1115: odronextamab in patients with relapsed/refractory diffuse large b-cell lymphoma: results from a prespecified analysis of the pivotal phase 2 study elm-2 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431082/ http://dx.doi.org/10.1097/01.HS9.0000971356.50570.ac |
| work_keys_str_mv | AT walewskijan p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT minkimtae p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT choseokgoo p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT jarqueisidro p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT iskierkajazdzewskaelzbieta p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT poonmichelle p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT milesprinceh p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT yongohsung p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT limfrancesca p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT seguraceciliacarmencarpio p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT tantrander p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT ayyappansabarish p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT gutierrezantonio p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT lijingjin p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT ufkinmelanie p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT zhumin p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT chaudhryaafia p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT mohamedhesham p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT ambatisrikanth p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 AT kimwonseog p1115odronextamabinpatientswithrelapsedrefractorydiffuselargebcelllymphomaresultsfromaprespecifiedanalysisofthepivotalphase2studyelm2 |